DETROIT (WWJ) – Chantix is the most popular anti-smoking drug on the market, but as WWJ’s Rob Sanford reports, it’s now being linked to a risk of heart disease.

Chantix rings up annual sales of $800 million and is currently used by seven million Americans in hopes of quitting smoking.

Now, several medical sources are saying it could be linked to a 72 percent higher chance of heart disease, especially for middle age users.

Pfizer manufactures the medication, and spokeswoman Dr. Gail Cawkwell disagrees with the findings.

“The cardiovascular events were infrequent. There were a small number of events in that they were similar in the two treatment groups,” Cawkwell said.

However, most patients currently on the medication agree the treatment works better than cold turkey and nicotine replacement therapy.

According to their website, Chantix does not contain nicotine. It targets nicotine receptors in the brain, attaches to them, and blocks nicotine from reaching them. It is believed that Chantix also activates these receptors, causing a reduced release of dopamine compared to nicotine.

On average it is estimated that smoking robs people of about 10 years of life.

  1. Forgetting to Inhale says:

    If smoking doesn’t get you the cure will. In the forgotten words of the late Yul Brynner, “don’t smoke”.

    We all need to participate in reducing healthcare costs. And there’s no butts about it.

Leave a Reply

Please log in using one of these methods to post your comment:

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

Watch & Listen LIVE